Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria. by Krishna, S, ter Kuile, F, Supanaranond, W, Pukrittayakamee, S, Teja-Isavadharm, P, Kyle, D, White, N

“…1 The pharmacokinetics, efficacy and toxicity of a new parenteral formulation of halofantrine hydrochloride were evaluated in 12 adults with acute uncomplicated falciparum malaria and nine adults who attended in convalescence. 2 Intravenous halofantrine (1 mg kg(-1) infused in 1 h) was given every 8 h for a total of three doses in the acute study. …”

Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria by Klein, K, Aarons, L, Ter Kuile, F, Nosten, F, White, N, Edstein, MD, Teja-Isavadharm, P

“…Aims To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in healthy volunteers and patients with symptomatic falciparum malaria. …”

Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria. by Klein, K, Aarons, L, Ter Kuile, F, Nosten, F, White, N, Edstein, MD, Teja-Isavadharm, P

“…AIMS: To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in healthy volunteers and patients with symptomatic falciparum malaria. …”